Skip to main content

Table 1 Costs applied in the Markov model, their distributions and the values used to estimate the distributions. Costs before 2019 have been discounted to the latest values

From: Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis

Parameter Value (€) (variation) Distribution Distribution values used in PSA (€)
Mean (SE) 		Source
Cost of recruitment* 24.5€ (18.4–30.6) Gamma 24.5 (3) Based on own results
Cost of intervention* 650 € (488–813) Gamma 650 (83) [21]
Additional health care costs of T2D excluding basic health care* 3315 € (2486–4144) Gamma 3315 (423) [22]
Cost of T2D complications* 4401€ (3301–5501) Gamma 4401 (561) [23]
Costs from productivity losses due to T2D a* 7632€ (5724–9540) Gamma 7632 (974) [24]
Additional T2D health care costs for basic health care 551 (SD 575) for men
533 (SD 635) for women 		Gamma Men = 551 (9.53)
Women = 533 (9.82) 		Based on own results
Additional medication costs of T2D* 584 (438–730) Gamma 584 (74) [25]
  1. a for persons under 65 years old *For variables without available confidence interval, a variation of ±25% has been used as an estimate. SE was calculated separately for additional T2D health care costs for basic health care. In other these cases, SE has been calculated as:
  2. \( SE=\frac{Mean\ast 1.25- Mean\ast 0.75}{2\ast 1.96} \)
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us